Andre Lamy
Expertise in
8
conditions

Andre Lamy

Hamilton, ON, CA 
Expertise in
8
conditions
Hamilton, ON, CA 

Overview

Andre Lamy practices practicing medicine in Hamilton, Canada.

Mr. Lamy is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Heart Attack, Coronary Heart Disease, Delirium, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

He is actively involved in clinical research, co-authoring 156 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Hamilton, ON, Canada
Other Locations
Hamilton, Canada
Toronto, ON, Canada
Newmarket, The University Of Toronto And Li Ka Shing Knowledge Institute Of St. Michael's Hospital, Quebec, QC, Canada
Calgary, AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery
Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery
Enrollment Status: Completed
Publish Date: July 31, 2025
A Cluster-randomized Factorial Crossover Trial, Comparing Antibiotic Mono-prophylaxis With Cefazolin vs. Dual-prophylaxis With Cefazolin Plus Vancomycin and Conventional Wound Dressing vs. Prevena Negative-pressure Wound Management
A Cluster-randomized Factorial Crossover Trial, Comparing Antibiotic Mono-prophylaxis With Cefazolin vs. Dual-prophylaxis With Cefazolin Plus Vancomycin and Conventional Wound Dressing vs. Prevena Negative-pressure Wound Management
Enrollment Status: Completed
Publish Date: February 28, 2025
Intervention Type: Other, Drug, Device
Study Phase: Phase 4
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery (The START Study)
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery (The START Study)
Enrollment Status: Completed
Publish Date: April 15, 2024
Intervention Type: Drug
Study Phase: Phase 2
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) Study
Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION) Study
Enrollment Status: Terminated
Publish Date: December 08, 2023
Intervention Type: Drug
Study Drug: Tranexamic Acid
Study Phase: Phase 3
Peri-Operative Pregabalin for Reducing opIoid Consumption AfTer Cardiac surgEry: A Randomized Trial
Peri-Operative Pregabalin for Reducing opIoid Consumption AfTer Cardiac surgEry: A Randomized Trial
Enrollment Status: Terminated
Publish Date: September 10, 2022
Intervention Type: Drug, Other
Study Phase: Phase 3
DEPOSITION: Pilot Study Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery
DEPOSITION: Pilot Study Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery
Enrollment Status: Completed
Publish Date: February 11, 2021
Intervention Type: Drug
Study Phase: Phase 4
Pilot Study of Preoperative Aspirin and Postoperative Clopidogrel's Effects on Graft Patency and Cardiac Events in Coronary Artery Bypass Surgery
Pilot Study of Preoperative Aspirin and Postoperative Clopidogrel's Effects on Graft Patency and Cardiac Events in Coronary Artery Bypass Surgery
Enrollment Status: Completed
Publish Date: August 03, 2017
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

156 Total Publications

A Scandinavian Perspective of the Projected Lifetime Cost-Effectiveness of Rivaroxaban Plus Aspirin in the COMPASS Trial.
A Scandinavian Perspective of the Projected Lifetime Cost-Effectiveness of Rivaroxaban Plus Aspirin in the COMPASS Trial.
Journal: Scandinavian cardiovascular journal : SCJ
Published: September 05, 2026

Frequently Asked Questions about Andre Lamy

Is Andre Lamy a top-rated expert for Heart Bypass Surgery?

MediFind is an objective health platform that identifies experts based on real-world data. Andre Lamy is classified as an Elite expert for Heart Bypass Surgery, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andre Lamy participate in research or clinical trials?

Yes. Andre Lamy has published 156 articles and abstracts on conditions like Heart Bypass Surgery. You can view a list of Andre Lamy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lamy's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile